TFN Reader Grapevine: 60%-plus just today—will the spike have legs?
Today's Financial News - Posted May 11, 2009
TFN eNews reader Tom E. believes something’s afoot at Cell Therapeutics, Inc. (NASDAQ:CTIC). Do you agree?
by J. Christoph Amberger
Baltimore—TFN: We at TFN consider ourselves a clearing house of good, solid, investment-related information. Which means we’re always glad to get tips or inside scoops from our readers. Since our editors are usually deep into their own research, we can’t follow up on all of the good information we receive. (Plus, our legal department doesn’t like us writing about stocks that trade at prices below $1.)
But every now and then, we just pass on the information to our readers.
If you choose to contact us with a bit of grapevine… make sure your e-text isn’t all that cryptic!
“Genta Incorporated (OTC:GNTA). Has Europe secure, U.S. soon with their bioproduct. Can go with and or complement all other chem in the world.”Dwayne F., Sent from iPhone, received Sunday night
Guess today’s 60%-plus gain speaks for itself.
What’s your assessment? Give us your input in the “Comments” field below!
Next Article: Converted Organics (COIN) up over 15% on open
4 Responses to “TFN Reader Grapevine: 60%-plus just today—will the spike have legs?”
Your comments are welcome
Follow TFN via RSS or Twitter |
 |
 |
 |
Advertisement
Latest Headlines
- The Big Picture for Sinobiopharma, Inc. (SNBP)
- Beazer Homes USA, Inc. (BZH) and Hovnanian Enterprises, Inc. (HOV) up despite horrid housing news
- The FDA catalyst: 2010 moves in MannKind (MNKD), Roche Holding (RHHBY), Acorda Therapeutics (ACOR) show it still works!
- Steepest drop since Feb. 2009: Here we go again!
- Is the silver run over? Coeur d’Alene Mines (CDE), Silver Wheaton (SLW), Alto Group (ALTO), Hecla Mining (HL), Endeavour Silver (EXK) close down
May 11th, 2009 at 11:52 am
About Therapeutics, Inc
USD 1.60… why?
Remember, this share already worth more than 2000 USD.
And if they have a new drug waiting aproval from FDA.
Just watch this share going skyrocket after a new aproval to a new cancer treatment.
May 11th, 2009 at 1:47 pm
The reason the stock price was in the thousands was because the volume was extremely low (less than a hundred-thousand shares a day). I highly doubt this stock goes over a 100 a share unless Pixantrone becomes the greatest drug known to man!
May 12th, 2009 at 8:14 am
CTIC is a great buy.
May 12th, 2009 at 6:44 pm
CTIC in 2011 = USD 2,800.00 per share. Its not a joke.